For over 20 years, Wipro has provided high quality medical device services to organizations across the world. Our global presence enables us to work closely with clients — ranging from startups to large manufacturers — and deliver tailored, localized solutions at competitive rates.
Wipro is ISO 13485 QMS certified and services a range of medical devices, software medical devices, consumer medical devices, in vitro diagnostic (IVD) devices, home care devices, wearable and connected devices, and drug device combination products. Wipro provides consulting services in post market surveillance, regulatory operations including EU MDR (European Union Medical Device Regulation) and EU IVDR (European Union In Vitro Diagnostic Regulation) remediation, medical writing, medical affairs, labeling remediation, quality operations including MDSAP implementation, customer support including multilingual contact center, product inquiries, and patient support programs for medical device manufacturers. The company’s services are designed to emphasize strategic and cost effective innovations to promote sustainable growth in the medical device industry.
Changes in the medical device regulatory framework, market globalization, mergers and acquisitions, and continuous innovation have led medical device companies to transition from legacy driven business models to more compliant, competitive, and customer-oriented service models. Wipro is continuously bringing cutting edge technology by introducing the next gen automation for each of the listed services. Our >1800 team members comprise PhDs, pharmacists, physicians, nurses, engineers, and life science professionals who have extensive experience in different therapeutic areas such as orthopedics, neurology, oncology, urology, metabolic disorders, ophthalmology, cardiology, dermatology, radiology, etc., to support medical device service needs in all areas.
Wipro delivers end to end pharmacovigilance solutions through consulting, technology, and operational teams. Our global delivery centers bring diverse talent groups and best in class technology to achieve customer goals. Our services support clinical and post marketing surveillance via case processing (ICSRs) and regulatory submission, literature search, periodic aggregate report writing, medical safety assessment, signal detection, and risk assessment.
We have >1000 dedicated pharmacovigilance resources, including physicians, pharmacists, nurses, and life science graduates who help our clients process 1.5 million cases annually. Our pharmacovigilance technology platform solution helps our pharma and consumer care customers reduce manual processing of cases and faster submission to regulatory authorities. With LEAN processes, we deliver value propositions to our clients in process efficiencies, commercial success, continuous monitoring of patient safety, and compliance with regulatory authorities.
Today, COVID-19 has drastically impacted global working models across industries, with no exception. Individuals in altered industries are working in varied shifts by successfully adopting a work-from-home model and delivering outputs per client obligations and regulatory compliance.